Frank F. Craig

Frank F. Craig serves as a Governor at Anglia Ruskin University (ARU), where he is part of the Board of Governors responsible for overseeing the university's strategic direction, financial management, and educational mission.1 His appointment to this role was announced in August 2022.3

Professional Background

Dr. Craig has an extensive background in management and leadership within the life sciences sector. He has accumulated approximately 35 years of international experience, including significant roles at GlaxoSmithKline and Amersham Biosciences, where he served as Vice-President of R&D.25 His career highlights include:

• Co-founding Aurora Biosciences, which reached a peak market capitalization of £1.8 billion before its acquisition by Vertex Pharmaceuticals for £420 million.
• Leading product development for innovative products such as Green Fluorescent Protein, recognized by the Nobel Prize in Chemistry in 2008.
• Raising substantial funds for various ventures, including £20 million in private equity and £25 million through an IPO on NASDAQ.24

Dr. Craig holds a PhD in Cell Biology and Microbiology from Glasgow University and an MBA from Warwick Business School, further enhancing his qualifications for his roles in both academia and industry.24

Role at Anglia Ruskin University

As a member of the Board of Governors, Dr. Craig contributes to shaping the university's policies and ensuring academic standards are met. The Board consists of up to 24 members, with a majority being independent members, emphasizing governance and oversight in alignment with the university's strategic goals.1

His leadership experience and background in life sciences position him well to influence ARU's direction, particularly in areas related to research and innovation within higher education.